Therapy resistant neonatal seizures, linear vesicular rash, and unusually early neuroradiological changes: incontinentia pigmenti: A case report, literature review and insight into pathogenesis by Kaczala, Gregor et al.
ORIGINAL PAPER
Therapy resistant neonatal seizures, linear vesicular
rash, and unusually early neuroradiological
changes: incontinentia pigmenti
A case report, literature review and insight into pathogenesis
Gregor W. Kaczala & Manuela A. Messer &
Ken J. Poskitt & Juliette S. Prendiville & Jane Gardiner &
Christof Senger
Received: 8 June 2007 /Revised: 17 September 2007 /Accepted: 21 September 2007 /Published online: 16 October 2007
# Springer-Verlag 2007
Abstract
Case presentation A substance abusing G2P1 mother
spontaneously delivered at term an appropriate for gesta-
tional age girl. Neonatal seizures appeared at 21 hours and
empiric anticonvulsive and antimicrobial treatment was
started. At 25 hours, first vesicles appeared. While routine
evaluations remained normal, a head CT revealed multifocal
ischemic injuries, and a later MRI showed multifocal
petechiae and diffusion abnormalities in the corticospinal
tracts. The clinical diagnosis of incontinentia pigmenti (stage
1) was secured by histopathology. Follow-up at 13 months
showed global developmental delay.
Discussion We discuss the unusually early bilateral, fronto-
occipital corticomedullar ischemias (CT day 3). On the MR
imaging (day 7) extensive symmetric cerebral corticomedullar
destruction and diffusion sequences with corticospinal tracts
abnormalities are seen, which then evolve (day 26) to
extensive symmetric cerebral destruction. We review the
literature, genetics, suspected pathophysiology and possible
neonatal manifestation.
Conclusion Incontinentia pigmenti is rare and, therefore,
diagnosis is frequently delayed. Nevertheless, in the setting
of therapy refractory seizures, excluded infections, and
linear vesicular rash, a high index of suspicion is needed.
This is the first report of simultaneous corticomedullar
involvement as early as the third day of life.
Keywords Neonatal . Seizure . Incontinentia pigmenti (IP) .
NEMO . NF-κB . IκB
Introduction
The neonatal diagnosis of incontinentia pigmenti (IP),
despite specific clinical features, is often delayed and made
by exclusion once the infectious work-up is negative. As in
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the setting of vesicular exanthemas and therapy resistant
seizures, neonates are empirically treated for suspected
neonatal herpes encephalitis and/or bacterial meningitis.
The clinical diagnosis is secured by pathognomonic
histological changes in the affected skin.
We would like to draw attention to this frequently
(initially) missed diagnosis and describe a girl with clinical
and histological features of IP and unusual simultaneous
corticomedullar involvement as early as 3 days of life, as
previous neuroradiological magnetic resonance imaging
(MRI) reports showed either white [20] or grey matter
involvement [48].
We review the current literature and discuss the known
pathophysiology.
Case presentation
A gravida 2, para 1 mother using crack, methyl-amphetamine,
cocaine, nicotine, and ethanol during pregnancy spontane-
ously delivered at term an adequate for gestational age girl
after 2 hours of ruptured membranes. Family history included
a grandmother with a brain aneurysm and a grandfather with
apoplexy. TORCH and Group B streptococcus screening were
negative. The immediate postnatal period was uneventful. At
21 hours of age, right arm jerking and eye deviation were
noted. Intermittently, the infant was pink, having a normal
muscular tone with a normal fontanel but weak suck.
Phenobarbital, ampicillin, gentamicin and acyclovir were
started. The initial hematological and chemical work-up was
normal, CSF was xanthochromic but sterile (incl. immune-
fluorescence testing for HSV). The blood culture grew
coagulase negative staphylococcus, which was regarded as a
contaminant. A head ultrasound showed a right sided grade I
intraventricular hemorrhage with a small germinolytic cyst.
Four hours after the seizure onset, linear vesicles along
the lines of Blaschko appeared. Despite therapeutic levels
of phenobarbital, apneas, profound desaturations, right
sided twitching, tongue protrusion, and eye deviation
persisted. The EEG showed an unspecific moderate
background suppression, multifocal spikes, and sharp
waves arousing from the left hemisphere.
On day 3 of life, a head CT showed bilateral, multifocal
ischemic injuries in the occipital and frontal areas (Fig. 1a).
On day 4, a diffuse maculo-papular rash over the trunk
and the upper extremities was thought to be a reaction to
phenobarbital. As seizures persisted, phenytoin was added.
On day 7, an MRI showed multifocal petechiae (Fig. 1b) and
abnormal diffusion of the corticospinal tracts (Fig. 1c).
Furthermore, echocardiography, coagulation, congenital
infection, and the inborn errors of metabolism screening
remained normal. A dermatologist suggested the diagnosis
of incontinentia pigmenti (IP), vesico-bullous stage (stage I,
Fig. 1e), which was confirmed by skin biopsy (Fig. 1f).
A laterMRI (day 26) showed extensive symmetric cerebral
destruction involving both gray and white matter (Fig. 1d),
corresponding to the areas of restricted diffusion documented
on day of life 7 (Fig. 1e). The MR-angiography showed
decreased intravascular flow in the middle cerebral arteries
but no structural changes. At that point, phenobarbital was a
Fig. 1 a Head CT (without
contrast, day 3): frontal and
occipital patchy low density
changes in the cortex and white
matter (white circles). b Head
MRI (T2, day 7): general white
matter hyperintensity with foci of
low signal intensity (black
circles). c Head MRI (day 7):
diffusion sequences with cortico-
spinal tracts abnormalities (white
circles). d Head MRI (T1, day
26): extensive symmetric cere-
bral destruction of gray and
white matter (white circles).
e Inside left leg (day 2): linear
vesicular exanthema along the
lines of Blaschko. f Skin biopsy
(H&E, 200x): IP, vesico-bullous
stage with pathognomonic intra-
epidermal eosinophils (*) and
vesicles (+), covered by the
stratum corneum (#)
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sufficient anticonvulsant therapy. Fundoscopy showed 360°
of peripheral avascularity in both eyes. Bilateral laser
coagulation to prevent neovascularization and retinal detach-
ment was performed and repeated at 3 months.
At 13 months of age, she presented with a severe
global developmental delay with intermittent seizures. The
skin was atrophic along the lines of Blaschko, and she
developed recurrent episodes of inflammatory vesicular
and verrucous skin lesions, usually associated with febrile
illnesses. No more imaging or EEG studies were
performed.
Discussion
We describe a newborn girl with clinical and histological
features of IP and with, as yet unreported, early simultaneous
corticomedullar involvement. The first report by Garrod in
1906 described the histological melanin deposits in the
corium, based on the concept that the corium was ‘inconti-
nent’ for melanin [12]. Later reports followed in 1925 [3] and
1926 [4]. The reported incidence is around 1:40,000 (M:F
ratio 1:37) [6]. IP is X-linked dominant and usually lethal in
males [46]. The reported living males were in the setting of
Klinefelter Syndrome or gonadal mosaicism [28, 37, 38].
The International Incontinentia Pigmenti Consortium
reported that IP is caused by a genomic rearrangement of
the gene for the nuclear factor kappa B (NF-κB) essential
modulator (NEMO) [42]. The gene is located 200 kb
proximal to the factor VIII locus and is required for the
activation of the transcription factor NF-κB which is central
to many immune, inflammatory, and apoptotic pathways [2,
14, 24]. In resting cells, NF-κB is kept inactive by inhibitory
proteins of the IκB family. NF-κB activation is induced by
the IκB Kinase (IKK) complex and NEMO [23, 25, 51].
After activation by inflammatory stimuli such as tumor
necrosis factor (TNF), interleukin-1 (IL-1), or bacterial
lipopolisaccharide (LPS), NF-κB is released and accumulat-
ed in the nucleus and activates its target genes [19]. NEMO
is essential for NF-κB activation by proinflammatory signals
[13]. Therefore, IP is due to genomic rearrangements which
make NF-κB activation defective [42].
In the mouse model, it is postulated that autonomous
proliferation of NEMO deficient keratinocytes, combined
with apoptosis of some NEMO-deficient cells, triggers the
expression of proinflammatory mediators by the neighbor-
ing wild-type keratinocytes resulting in the development of
the cutaneous lesions [32]. Nevertheless, several mecha-
nisms triggering the disease remain unanswered. Nenci at
al. suggest that the cutaneous lesions are triggered by the
presence of NEMO-deficient cells but that the mosaic
presence of NEMO-deficient and wild-type keratinocytes is
not needed for disease induction [32]. On the other hand, as
apoptosis is a prominent feature in NEMO deficient
keratinocytes, their replacement by wild-type cells is
thought to explain the cutaneous healing [39]. The
pathophysiology of the cerebral lesions is not fully
understood [34].
Four clinical stages are defined:
– Stage 1, vesico-bullous (first 2 weeks of life): vesicles
and erythema along Blaschko’s lines
– Stage 2, verrucous (after several weeks, lasting for
weeks): hyperkeratosis, verrucosis on erythematous
base. Usually lower limbs. Evolving from stage 1 or
unaffected skin
– Stage 3, hyperpigmentation (3–6 months, lasting
months to years): asymmetrical, hyperpigmented
streaks/whorls along Blaschko’s lines
– Stage 4, hypopigmentation (late infancy and adoles-
cence): skin atrophy typically on the flexor side of
lower limbs
The most commonly described presenting symptoms in
the neonatal period are vesicular rash, exanthema, therapy
refractory seizures, paresis [22, 40, 45], and head circum-
ference increase [41]. More unusual features include
persistent pulmonary hypertension (PPHN) [16], alopezia
[16, 47], or in the later neonatal period, low concentrations
of IgG subclasses [33].
The differential diagnosis of the vesico-bullous stage
includes neonatal infections (herpes simplex, herpes zoster,
candidiasis, or syphilis) and various congenital cutaneous
conditions (impetigo bullosa, epidermolysis bullosa simplex,
transient neonatal pustular melanosis, drug induced rash,
hyperkeratosis epidermolytica, and dermatitis herpetiforme)
[6, 8, 10, 18, 29].
Our neuroradiological findings are unusual, as previous
reports from the neonatal period have mentioned:
– Cortical atrophy and ventricular enlargement (CT on
day 2) [49]
– Polymicrogyria in the perisylvan area and cortical
dysplasia (MRI on day 5) [16]
– Cortical necrosis with subcortical hemorrhage (MRI on
day 3) [48]
– Restricted diffusion in the periventricular area (MRI on
day 8) and filling defects in the middle cerebral artery
(MR-angiography on day 13) [21]
– Diffuse hemispheric hemorrhagic necrosis (MRI on day
15) [41]
MRI findings in older children include periventricular
leukomalacia [31, 40], cerebellar abnormalities [35], corpus
callosum hypoplasia [31], encephalomalacia [9], multiple
cerebral infarctions [26], vascular abnormalities [21, 30],
unilateral middle cerebral artery occlusion [36], and
transient white matter injury [50].
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However, presence of changes in the neuroradiolog-
ical imaging does not necessarily mean neurodevelop-
mental impairment [5]. The pathophysiology of the
cerebral and retinal problems have not yet been observed
in NEMO +/− mice yet. Therefore, the pathophysiology is
not yet understood, and an inflammatory origin is
speculated [1].
Our patient was prenatally exposed to cocaine but our
radiological findings are not explained by this factor.
King et al. reported that neurosonographic structural
changes were not more frequent than in healthy controls
and were of similar nature [27]. In their cohort, the blood
flow in the anterior cerebral artery of cocaine exposed
babies increased from day 1 to day 2 and was not
explained by a difference in blood pressure. Our observa-
tion was a decreased flow in the middle cerebral artery, as
had also been seen by others [21]. Other authors reported
an association between antenatal cocaine exposure and
schizencephaly, interhemispheric cysts [15], pachygyria
[17], periventricular leukomalacia [20], cerebral infarction
[7], and intraventricular hemorrhage [43].
Our case was diagnosed clinically by the dermatologist
and confirmed by histopathology. Therefore, in the pres-
ence of a vesicular exanthema following the lines of
Blaschko, persisting seizures, and excluded infection, a
high index of suspicion is needed. Noteworthy are two
previous reports showing coexistence of IP and neonatal
HSV infection [11, 44]. Diagnosis is be confirmed by
pathognomonic histology.
The prognostic value of imaging is controversial, as one
report describes cerebral features of IP in a neurologically
normal child [5], whereas in a retrospective cohort,
neuroradiological changes are only seen in symptomatic
patients [33]. Fundoscopy is mandatory as ocular involve-
ment is frequent; intervention may be necessary and related
to neurological involvement. Furthermore, after discharge,
periodic ophthalmological and neurological follow-up visits
are recommended as well as punctual stomatological
controls.
Conclusion
We present a classical case of IP with unusual neuroradio-
logical findings: early diffusion changes and the evolution
of initial cortical and white matter hemorrhage into diffuse
necrosis and atrophy. This natural progression most likely
explains the global developmental delay observed at
13 months.
The reports in the MRI era describe few neonates with
white matter or cortical involvement, with one case of
transient white matter injury.
Although neurological symptoms are frequent in IP, the
mechanisms of cerebral involvement are not yet fully
understood and further research is needed.
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